Managed Care Weekly Digest
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Nanopeutics signs technology agreement with HemCon Medical Technologies for military market
February 12th, 2007
Alltracel Pharmaceuticals Plc. (AIM) announced that Nanopeutics s.r.o., the company's subsidiary, has signed a technology and product concept development agreement with HemCon Medical Technologies, Inc. a company in the hemorrhage control market focused on military markets. Alltracel is a medical technology company focused on the wound care, oral care and cardiovascular health markets. Nanopeutics is focused on commercializing Nanospider technology. The successful conclusion to the development work, which has already commenced following successful initial product tests, is expected to lead to a license and supply agreement for a range of chitosan...
Source: Managed Care Weekly Digest (2007-02-12)
|
